[PDF][PDF] The effect of JAK1/JAK2 inhibition in rheumatoid arthritis: efficacy and safety of baricitinib

EHS Choy, C Miceli-Richard… - Clin Exp …, 2019 - clinexprheumatol.org
Numerous cytokines have been implicated in the pathogenesis of inflammatory diseases,
and their dysregulation is a main feature of rheumatoid arthritis (RA). Cytokines stimulate …

Vaccination of patients with autoimmune inflammatory rheumatic diseases

J Westra, C Rondaan, S Van Assen… - Nature Reviews …, 2015 - nature.com
Patients with autoimmune inflammatory rheumatic diseases (AIRDs) are at increased risk of
infections. This risk has been further increased by the introduction of biologic agents over …

Systemic lupus erythematosus and infections

BK Singh, S Singh - Reumatismo, 2020 - reumatismo.org
Systemic lupus erythematosus (SLE) is an inflammatory and multi-systemic autoimmune
disorder, characterized by an uncontrolled auto-reactivity of B and T lymphocytes, leading to …

Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta …

M Pugès, P Biscay, T Barnetche, MÉ Truchetet… - …, 2016 - academic.oup.com
Objectives. The aim was to assess the immunogenicity and the impact on disease activity of
pneumococcal and influenza vaccines in SLE patients. Methods. We conducted a systematic …

[HTML][HTML] Incidence of invasive pneumococcal disease in immunocompromised patients: a systematic review and meta-analysis

M van Aalst, F Lötsch, R Spijker… - Travel medicine and …, 2018 - Elsevier
Background Invasive pneumococcal disease (IPD) is associated with high morbidity and
mortality, with immunocompromised patients (ICPs) at particular risk. Therefore, guidelines …

Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept

R Alten, CO Bingham, SB Cohen, JR Curtis… - BMC musculoskeletal …, 2016 - Springer
Background Patients with rheumatoid arthritis (RA), including those treated with biologics,
are at increased risk of some vaccine-preventable infections. We evaluated the antibody …

Ophthalmological considerations for COVID-19 vaccination in patients with inflammatory eye diseases and autoimmune disorders

CYC Chau, LLW Chow, S Sridhar, KC Shih - Ophthalmology and Therapy, 2021 - Springer
The global impact imposed by the coronavirus disease 2019 (COVID-19) pandemic may be
soon alleviated by the introduction and worldwide dissemination of safe and effective …

[HTML][HTML] Diagnosis and treatment of lupus nephritis. Consensus document from the systemic auto-immune disease group (GEAS) of the Spanish Society of Internal …

G Ruiz Irastorza, G Espinosa… - Nefrología (English …, 2012 - revistanefrologia.com
METHODS Both scientific societies proposed five representatives that held their first meeting
in Barcelona on 17 June 2010. At this meeting, the participants elaborated a list of concrete …

Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases–a longitudinal study

L Fischer, PF Gerstel, A Poncet, CA Siegrist… - Arthritis research & …, 2015 - Springer
Introduction Patients undergoing immunosuppressive therapy are at increased risk of
infection. Community-acquired pneumonia and invasive pneumococcal disease account for …

Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases

CGS Saad, EF Borba, NE Aikawa, CA Silva… - Annals of the …, 2011 - ard.bmj.com
Background Despite the WHO recommendation that the 2010–2011 trivalent seasonal flu
vaccine must contain A/California/7/2009/H1N1-like virus there is no consistent data …